Recommended Medications for Intubation
For rapid sequence intubation (RSI), the recommended first-line medications are etomidate (0.2-0.3 mg/kg IV) or ketamine (1-2 mg/kg IV) as sedative-hypnotic agents, combined with succinylcholine (1.5 mg/kg IV) or rocuronium (0.9-1.2 mg/kg IV) as neuromuscular blocking agents. 1, 2
Sedative-Hypnotic Agents
First-line options:
Etomidate (0.2-0.3 mg/kg IV)
Ketamine (1-2 mg/kg IV)
- Recommended for patients with septic or hypovolemic shock
- Provides analgesia and amnesia
- Maintains or increases blood pressure through sympathomimetic effects
- May increase intracranial pressure (relative contraindication in head injury) 2
Alternative options:
Propofol (1-2.5 mg/kg IV)
- Avoid in hemodynamically unstable patients
- Causes significant vasodilation and hypotension
- Rapid onset and short duration 2
Midazolam (0.2 mg/kg IV)
- Longer onset time compared to other agents
- Can cause significant hypotension at RSI doses
- Less effective as a sole agent for RSI 1
Neuromuscular Blocking Agents
First-line options:
Succinylcholine (1.5 mg/kg IV)
- Fastest onset (30-60 seconds) and shortest duration (5-10 minutes)
- Contraindications: hyperkalemia, malignant hyperthermia risk, burns, crush injuries, denervation injuries 1
Rocuronium (0.9-1.2 mg/kg IV)
Pre-Intubation Considerations
Pre-oxygenation
- Non-invasive ventilation recommended for hypoxemic patients
- High-flow nasal oxygen can be used, especially for non-severely hypoxemic patients 1
Adjunctive medications
Medication Selection Algorithm
Hemodynamically stable patient
- Sedative: Etomidate (0.2-0.3 mg/kg) or Propofol (1-2.5 mg/kg)
- Paralytic: Succinylcholine (1.5 mg/kg) if no contraindications, otherwise Rocuronium (0.9-1.2 mg/kg)
Hemodynamically unstable patient
- Sedative: Etomidate (0.2-0.3 mg/kg) or Ketamine (1-2 mg/kg)
- Paralytic: Rocuronium (0.9-1.2 mg/kg) or Succinylcholine (1.5 mg/kg)
Septic patient
Head injury with increased ICP
- Sedative: Etomidate (0.2-0.3 mg/kg)
- Paralytic: Either Succinylcholine or Rocuronium
- Consider mannitol (0.25-1 g/kg) for acute intracranial hypertensive crisis 1
Special Considerations
COVID-19 patients: Modified rapid sequence induction with sufficient muscle paralysis after loss of consciousness. Midazolam 2-5 mg with etomidate (10-20 mg) or propofol for induction, fentanyl 100-150 μg or sufentanil 10-15 μg, and succinylcholine 1 mg/kg or rocuronium 1 mg/kg 1
Pediatric patients: Etomidate is recommended for children >2 years except in sepsis. Ketamine (3-4 mg/kg before 18 months, 2 mg/kg after) is an alternative 1
Common Pitfalls and Caveats
Inadequate dosing: Ensure adequate doses of both sedative and paralytic agents to achieve optimal intubating conditions 6
Failure to anticipate hemodynamic effects: Have vasopressors immediately available, especially when using propofol or midazolam 2
Ignoring contraindications: Be aware of specific contraindications for each agent (e.g., succinylcholine in hyperkalemia, etomidate in sepsis) 3, 4
Inadequate preparation: Ensure all equipment is ready and functioning before administering medications 1
Neglecting post-intubation sedation: Plan for ongoing sedation after RSI medications wear off to prevent awareness during paralysis 2
Remember that the choice of intubation medications should be guided by the patient's clinical condition, with particular attention to hemodynamic status, neurological status, and underlying pathology.